[go: up one dir, main page]

PE20081785A1 - Derivados de ciclohexil-amida del acido aril carboxilico - Google Patents

Derivados de ciclohexil-amida del acido aril carboxilico

Info

Publication number
PE20081785A1
PE20081785A1 PE2008000326A PE2008000326A PE20081785A1 PE 20081785 A1 PE20081785 A1 PE 20081785A1 PE 2008000326 A PE2008000326 A PE 2008000326A PE 2008000326 A PE2008000326 A PE 2008000326A PE 20081785 A1 PE20081785 A1 PE 20081785A1
Authority
PE
Peru
Prior art keywords
cyclohexyl
hydroxy
amide derivatives
carboxyl acid
aryl carboxyl
Prior art date
Application number
PE2008000326A
Other languages
English (en)
Inventor
Rene Hersperger
Phillip Janser
Wolfgang Miltz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20081785A1 publication Critical patent/PE20081785A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE X ES CH2, NH; n ES 1-2; R ES CICLOALQUILO 3-18 ATOMOS DE CARBONO, HETEROCICLOALQUILO DE 3-18 ATOMOS DE CARBONO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: {4-HIDROXI-4-[2-((3S,4S)-4-HIDROXI-3-METIL-PIPERIDIN-1-IL)-ETIL]-CICLOHEXIL}-AMIDA DEL ACIDO 4-CICLOBUTIL-METOXI-1H-INDOL-2-CARBOXILICO; {4-HIDROXI-4-[2-((3S,4S)-4-HIDROXI-3-METIL-PIPERIDIN-1-IL)ETIL]CICLOHEXIL}-AMIDA DEL ACIDO 4-(4-OXO-4,5,6,7-TETRAHIDRO-BENZO-FURAN-3-IL-METOXI)-1H-INDOL-2-CARBOXILICO; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE INFECCION POR VIH
PE2008000326A 2007-02-19 2008-02-15 Derivados de ciclohexil-amida del acido aril carboxilico PE20081785A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07102622 2007-02-19

Publications (1)

Publication Number Publication Date
PE20081785A1 true PE20081785A1 (es) 2009-01-12

Family

ID=38058317

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000326A PE20081785A1 (es) 2007-02-19 2008-02-15 Derivados de ciclohexil-amida del acido aril carboxilico

Country Status (35)

Country Link
US (1) US8354431B2 (es)
EP (1) EP2125782B1 (es)
JP (1) JP5180234B2 (es)
KR (1) KR101070984B1 (es)
CN (1) CN101605781B (es)
AR (1) AR065369A1 (es)
AT (1) ATE518854T1 (es)
AU (1) AU2008219317B2 (es)
BR (1) BRPI0807625A2 (es)
CA (1) CA2677565C (es)
CL (1) CL2008000497A1 (es)
CR (1) CR10957A (es)
CY (1) CY1111984T1 (es)
DK (1) DK2125782T3 (es)
EA (1) EA017000B1 (es)
EC (1) ECSP099584A (es)
ES (1) ES2371126T3 (es)
GT (1) GT200900226A (es)
HN (1) HN2009001607A (es)
HR (1) HRP20110793T1 (es)
IL (1) IL200191A (es)
MA (1) MA31206B1 (es)
MX (1) MX2009008145A (es)
MY (1) MY147487A (es)
NZ (1) NZ578663A (es)
PE (1) PE20081785A1 (es)
PL (1) PL2125782T3 (es)
PT (1) PT2125782E (es)
RS (1) RS51986B (es)
SI (1) SI2125782T1 (es)
TN (1) TN2009000345A1 (es)
TW (1) TW200848038A (es)
UA (1) UA97389C2 (es)
WO (1) WO2008101905A1 (es)
ZA (1) ZA200905160B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273900B2 (en) 2008-08-07 2012-09-25 Novartis Ag Organic compounds
CA3200234A1 (en) 2020-11-25 2022-06-02 Daryl C. Drummond Lipid nanoparticles for delivery of nucleic acids, and related methods of use
IL317109A (en) 2022-05-25 2025-01-01 Akagera Medicines Inc Lipid nanoparticles for the delivery of nucleic acids and methods of using them

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132987A (en) 1994-01-13 2000-10-17 The Regents Of The University Of California Recombinant mammalian monocyte chemotactic protein-1 (MCP-1) receptors (MCP-1R, CCR-2)
WO1997032019A2 (en) 1996-03-01 1997-09-04 Euroscreen S.A. C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
EP0975749A2 (en) * 1996-05-28 2000-02-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cc chemokine receptor 5, antibodies thereto, transgenic animals
US6388055B1 (en) 1996-10-03 2002-05-14 Smithkline Beecham Corporation Mouse CC-CKR5 receptor polypeptide
AR008331A1 (es) 1997-01-23 1999-12-29 Smithkline Beecham Corp Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen
US6172061B1 (en) * 1997-12-19 2001-01-09 Takeda Chemical Industries, Ltd. Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative
US6312689B1 (en) * 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US6235771B1 (en) * 1998-12-21 2001-05-22 Takeda Chemical Industries, Ltd. Anilide derivative, production and use thereof
AU2000227285A1 (en) 2000-01-14 2001-07-24 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods of regulating il-12 production by administering ccr5 agonists and antagonists
WO2002020615A2 (en) 2000-09-08 2002-03-14 Micromet Ag Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
CA2463198A1 (en) 2001-10-03 2003-04-17 Ucb, S.A. Pyrrolidinone derivatives
WO2004054616A1 (ja) * 2002-12-13 2004-07-01 Ono Pharmaceutical Co., Ltd. ケモカイン受容体の強結合部位に結合するアンタゴニストおよびアゴニスト
EP1623721A1 (en) * 2003-05-06 2006-02-08 Ono Pharmaceutical Co., Ltd. Effector cell function inhibitor
CA2548502A1 (en) * 2003-12-11 2005-06-30 Yale University Methods and compositions relating to ccr5 antagonist, ifn-.gamma. and il-13 induced inflammation
NZ547316A (en) 2003-12-18 2011-01-28 Incyte Corp 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
US7435831B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
CA2565486A1 (en) * 2004-05-11 2005-12-08 Incyte Corporation 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
GB0412468D0 (en) 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
WO2007062175A2 (en) 2005-11-21 2007-05-31 Amgen Inc. Spiro-substituted tricyclic heterocycles cxcr3 antagonists
GB0525957D0 (en) 2005-12-21 2006-02-01 Astrazeneca Ab Methods
BRPI0712843A2 (pt) 2006-06-12 2012-07-31 Pfizer Prod Inc antagonista de ccr5 e seus usos
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
MX2009003762A (es) 2006-10-05 2009-07-10 Centocor Ortho Biotech Inc Antagonistas del receptor cc-quimiocina 2 para el tratamiento de fibrosis.
WO2008045564A2 (en) 2006-10-12 2008-04-17 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
MX2009005252A (es) 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
EP2120928A2 (en) 2007-02-15 2009-11-25 Pfizer Limited Pharmaceutical compositions and methods for ccr5 antagonists
WO2008134076A1 (en) 2007-04-30 2008-11-06 Progenics Pharmaceuticals, Inc. Methods for reducing viral load in hiv-1-infected patients

Also Published As

Publication number Publication date
HN2009001607A (es) 2011-11-23
GT200900226A (es) 2010-07-02
CY1111984T1 (el) 2015-11-04
DK2125782T3 (da) 2011-11-21
AR065369A1 (es) 2009-06-03
US20100016361A1 (en) 2010-01-21
HRP20110793T1 (hr) 2011-11-30
TW200848038A (en) 2008-12-16
CA2677565C (en) 2014-11-18
NZ578663A (en) 2011-01-28
HK1138836A1 (en) 2010-09-03
JP2010519187A (ja) 2010-06-03
KR101070984B1 (ko) 2011-10-06
AU2008219317A1 (en) 2008-08-28
BRPI0807625A2 (pt) 2014-05-27
MX2009008145A (es) 2009-08-12
TN2009000345A1 (en) 2010-12-31
ZA200905160B (en) 2010-05-26
EP2125782B1 (en) 2011-08-03
CN101605781A (zh) 2009-12-16
ES2371126T3 (es) 2011-12-27
US8354431B2 (en) 2013-01-15
IL200191A0 (en) 2010-04-15
PL2125782T3 (pl) 2011-12-30
ATE518854T1 (de) 2011-08-15
WO2008101905A1 (en) 2008-08-28
EP2125782A1 (en) 2009-12-02
EA200901085A1 (ru) 2010-02-26
KR20090103943A (ko) 2009-10-01
EA017000B1 (ru) 2012-09-28
JP5180234B2 (ja) 2013-04-10
PT2125782E (pt) 2011-11-17
SI2125782T1 (sl) 2011-12-30
RS51986B (en) 2012-02-29
CL2008000497A1 (es) 2008-08-29
AU2008219317B2 (en) 2011-09-08
CN101605781B (zh) 2014-08-13
MA31206B1 (fr) 2010-02-01
UA97389C2 (en) 2012-02-10
ECSP099584A (es) 2009-09-29
MY147487A (en) 2012-12-14
CA2677565A1 (en) 2008-08-28
CR10957A (es) 2009-09-01
IL200191A (en) 2013-12-31

Similar Documents

Publication Publication Date Title
PE20141004A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
PE20091523A1 (es) Derivados de tiazol como inhibidores de la enzima fosfatidilinositol 3-cinasa (pi3k)
PE20121500A1 (es) 2-amino-5,5-difluor-5,6-dihidro-4h-oxazinas como inhibidores de bace 1 y/o bace 2
PE20120690A1 (es) Derivados de 5-fluoropirimidinona
PE20050121A1 (es) Acidos tienil-hidroxamicos, sustituidos referidos a la actividad enzimatica de la histona desacetilasa
PE20090183A1 (es) Derivados de 1-oxa-3,9-diaza-espiro-[5.5]undecan-2-ona como moduladores de ccr5
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
PE20130281A1 (es) Derivados de acido 5-alquinil-3-amida-2-tiofeno-carboxilico como inhibidores del virus flaviviridae
PE20142185A1 (es) Pirrolidina-2-carboxamidas sustituidas
PE20090326A1 (es) Compuestos heterociclos como inhibidores de erk
PE20130311A1 (es) Composiciones y metodos para modular la via de senalizacion de wnt
PE20081505A1 (es) Inhibidores de serina palmitoiltransferasa
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
PE20091972A1 (es) Compuestos heterociclicos como inhibidores del factor ixa
PE20120620A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
PE20080768A1 (es) Compuestos de isoindolina 5-sustituidos
PE20121010A1 (es) Derivados de bencimidazol
PE20121522A1 (es) Derivados de acido 5-alquinil-3-amida-2-tiofeno-carboxilico como inhibidores del virus flaviviridae
PE20130009A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
PE20090649A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20110367A1 (es) DERIVADOS DE 4-CIANO-4-FENIL-PIRROLIDIN-2-CARBOXAMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA INTERACCION p53-MDM2
UY32336A (es) Nuevos compuestos de acido 2-({ [(1Z)-1-2(2-amino-1,3-tiazol-4-il)-2-{ [(3S)-1-({ [5-hidroxi-4-oxo-1,4-dihidropiridin-2-il)-5-oxo-4-propil-4, 5 - dihidro - 1H - 1, 2, 4 - trialzol - 1 - il]sulfonil} carbamoil) -2 - oxazetidin -3 -il] amino} - 2 - oxoetiliden] amino} oxi) - 2 - metilpropanoico, composiciones farmacéuticas conteniendolos y aplicaciones.
PE20100093A1 (es) Derivados de acetileno
PE20060937A1 (es) Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2)
MX2009003383A (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed